DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 46 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $26,224,828 | -25.7% | 1,903,108 | -11.0% | 0.00% | -33.3% |
| Q1 2024 | $35,311,351 | +14.1% | 2,137,491 | +0.9% | 0.01% | 0.0% |
| Q4 2023 | $30,935,196 | +53.2% | 2,118,849 | +28.7% | 0.01% | +50.0% |
| Q3 2023 | $20,198,813 | -29.3% | 1,646,195 | -31.2% | 0.00% | -33.3% |
| Q2 2023 | $28,566,725 | -6.4% | 2,392,523 | +4.8% | 0.01% | -14.3% |
| Q1 2023 | $30,528,203 | -19.8% | 2,283,336 | +29.1% | 0.01% | -22.2% |
| Q4 2022 | $38,049,556 | +110013.0% | 1,768,102 | +2.5% | 0.01% | 0.0% |
| Q3 2022 | $34,555 | +1.9% | 1,725,142 | -8.9% | 0.01% | +12.5% |
| Q2 2022 | $33,912 | -89.1% | 1,894,537 | +5969.9% | 0.01% | – |
| Q1 2022 | $310,000 | -25.1% | 31,212 | +27.2% | 0.00% | – |
| Q4 2021 | $414,000 | +56.8% | 24,546 | +111.7% | 0.00% | – |
| Q2 2021 | $264,000 | – | 11,594 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,965,588 | $113,066,000 | 1.82% |
| Boxer Capital, LLC | 1,189,943 | $27,095,000 | 0.96% |
| BVF INC/IL | 918,975 | $20,925,000 | 0.78% |
| Samsara BioCapital, LLC | 202,500 | $4,611,000 | 0.57% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 818,980 | $18,648,000 | 0.33% |
| Perceptive Advisors | 1,512,094 | $34,430,000 | 0.22% |
| Rock Springs Capital Management LP | 373,739 | $8,510,000 | 0.17% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 434,423 | $9,892,000 | 0.13% |
| HealthCor Management, L.P. | 103,717 | $2,362,000 | 0.09% |
| VIKING GLOBAL INVESTORS LP | 1,341,396 | $30,544,000 | 0.09% |